061250.KS · 화일약품
South Korea · RS rating 4 · As of 2026-10-14
| Price | 6,110.00 KRW |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 4 / 6 / 14 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 11 / 44 |
| Industry group (rank) | Medical-Generic Drugs (76) |
| EPS growth Q/Q | +642.9% |
| Sales growth Q/Q | +4.4% |
| Distance from 52-week high | +49.1% |
| Market cap (USD) | $40.7M |